Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_provenance.
- NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_assertion description "[Some patient characteristics, such as never-smoking, female gender, East Asian origin, adenocarcinoma histology, and bronchioloalveolar subtype, are associated with a greater benefit from treatment with EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_provenance.
- NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_assertion evidence source_evidence_literature NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_provenance.
- NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_assertion SIO_000772 16270096 NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_provenance.
- NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_assertion wasDerivedFrom befree-2016 NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_provenance.
- NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_assertion wasGeneratedBy ECO_0000203 NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_provenance.
- befree-2016 importedOn "2016-02-19" NP521037.RAwRMHrXyeEcvEw3GCO7dek5TjZ1rLX3kRqjrTUnOrGZA130_provenance.